In vitro activities of different inhibitors of bacterial transcription against Staphylococcus epidermidis biofilm

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 9, 2007, Pages 3117-3121

  Villain Guillot, Philippe ^a   Gualtieri, Maxime ^a   Bastide, Lionel ^b   Leonetti, Jean Paul ^a  

^a UNIV MONTPELLIER   (France)

^b Selectbiotics   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CBR 64; CBR 703; HOLOMYCIN; LIPIARMYCIN; RIFAMPICIN; RIFAPENTINE; RIFAXIMIN; RNA POLYMERASE; SB 2; STREPTOLYDIGIN; THIOLUTIN; THIOPHENE DERIVATIVE; UNCLASSIFIED DRUG; UREIDOTHIOPHENE;

ARTICLE; BACTERIUM DETECTION; BIOFILM; DRUG STRUCTURE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RNA TRANSCRIPTION; STAPHYLOCOCCUS EPIDERMIDIS; TRANSCRIPTION REGULATION;

AMIDINES; ANTI-BACTERIAL AGENTS; BIOFILMS; COLONY COUNT, MICROBIAL; DNA-DIRECTED RNA POLYMERASES; ENZYME INHIBITORS; HYDROXYLAMINES; LUMINESCENCE; RIFAMPIN; STAPHYLOCOCCUS EPIDERMIDIS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION, GENETIC;

EID: 35949002764     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00343-07     Document Type: Article

References (31)

1. Ackermann, G., B. Loffler, D. Adler, and A. C. Rodloff. 2004. In vitro activity of OPT-80 against Clostridium difficile. Antimicrob. Agents Chemother. 48:2280-2282.
2. André, E., L. Bastide, S. Michaux-Charachon, A. Gouby, P. Villain-Guillot, J. Latouche, A. Bouchet, M. Gualtieri, and J. P. Leonetti. 2006. Novel synthetic molecules targeting the bacterial RNA polymerase assembly. J. Antimicrob. Chemother. 57:245-251.
3. Arhin, F., O. Belanger, S. Ciblat, M. Dehbi, D. Delorme, E. Dietrich, D. Dixit, Y. Lafontaine, D. Lehoux, J. Liu, G. A. McKay, G. Moeck, R. Reddy, Y. Rose, R. Srikumar, K. S. Tanaka, D. M. Williams, P. Gros, J. Pelletier, T. R. Parr, Jr., and A. R. Far. 2006. A new class of small molecule RNA polymerase inhibitors with activity against rifampicin-resistant Staphylococcus aureus. Bioorg. Med. Chem. 14:5812-5832.
4. Artsimovitch, I., C. Chu, A. S. Lynch, and R. Landick. 2003. A new class of bacterial RNA polymerase inhibitor affects nucleotide addition. Science 302:650-654.
5. Coronelli, C., R. J. White, G. C. Lancini, and F. Parenti. 1975. Lipiarmycin, a new antibiotic from Actinoplanes. II. Isolation, chemical, biological and biochemical characterization. J. Antibiot. 28:253-259.
6. Engelberg-Kulka, H., R. Hazan, and S. Amitai. 2005. mazEF: a chromosomal toxin-antitoxin module that triggers programmed cell death in bacteria. J. Cell Sci. 118:4327-4332.
7. Fux, C. A., J. W. Costerton, P. S. Stewart, and P. Stoodley. 2005. Survival strategies of infectious biofilms. Trends Microbiol. 13:34-40.
8. Gracia, E., A. Fernandez, P. Conchello, J. L. Alabart, M. Perez, and B. Amorena. 1999. In vitro development of Staphylococcus aureus biofilms using slime-producing variants and ATP-bioluminescence for automated bacterial quantification. Luminescence 14:23-31.
9. Gualtieri, M., L. Bastide, P. Villain-Guillot, S. Michaux-Charachon, J. Latouche, and J. P. Leonetti. 2006. In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms. J. Antimicrob. Chemother. 58:778-783.
10. Gualtieri, M., P. Villain-Guillot, J. Latouche, J. P. Leonetti, and L. Bastide. 2006. Mutation in the Bacillus subtilis RNA polymerase β′ subunit confers resistance to lipiarmycin. Antimicrob. Agents Chemother. 50:401-402.
11. Hall-Stoodley, L., J. W. Costerton, and P. Stoodley. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2:95-108.
12. Hunter, R. C., and T. J. Beveridge. 2005. Application of a pH-sensitive fluoroprobe (C-SNARF-4) for pH microenvironment analysis in Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol. 71:2501-2510.
13. Keren, I., N. Kaldalu, A. Spoering, Y. Wang, and K. Lewis. 2004. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230:13-18.
14. Leonetti, J.-P., E. André, and L. Bastide. 2006. Antibiotic thiazolidines. Patent WO 2005/020990.
15. Lewis, K. 2005. Persister cells and the riddle of biofilm survival. Biochemistry 70:267-274.
16. Lewis, K. 2007. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 5:48-56.
17. Li, L., X. Chen, P. Fan, J. T. Mihalic, and S. Cutler. 2001. Patent WO 2001/51456.
18. Monzon, M., C. Oteiza, J. Leiva, and B. Amorena. 2001. Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis. J. Antimicrob. Chemother. 48:793-801.
19. Monzon, M., C. Oteiza, J. Leiva, M. Lamata, and B. Amorena. 2002. Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics. Diagn. Microbiol. Infect. Dis. 44:319-324.
20. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard M07-A6. NCCLS, Wayne, PA.
21. O'Gara, J. P., and H. Humphreys. 2001. Staphylococcus epidermidis biofilms: importance and implications. J. Med. Microbiol. 50:582-587.
22. Oliva, B., A. O'Neill, J. M. Wilson, P. J. O'Hanlon, and I. Chopra. 2001. Antimicrobial properties and mode of action of the pyrrothine holomycin. Antimicrob. Agents Chemother. 45:532-539.
23. O'Neill, A., B. Oliva, C. Storey, A. Hoyle, C. Fishwick, and I. Chopra. 2000. RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 44:3163-3166.
24. Pandey, D. P., and K. Gerdes. 2005. Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res. 33:966-976.
25. Rinehart, K. L., Jr., J. R. Beck, D. B. Borders, W. W. Epstein, T. H. Kinstle, L. D. Spicer, D. Krauss, and A. C. Button. 1963. Structure of streptolydigin. Antimicrob. Agents Chemother. 161:346-348.
26. Sat, B., R. Hazan, T. Fisher, H. Khaner, G. Glaser, and H. Engelberg-Kulka. 2001. Programmed cell death in Escherichia coli: some antibiotics can trigger mazEF lethality. J. Bacteriol. 183:2041- 2045.
27. Severinov, K., M. Soushko, A. Goldfarb, and V. Nikiforov. 1993. Rifampicin region revisited. New rifampicin-resistant and streptolydigin- resistant mutants in the beta subunit of Escherichia coli RNA polymerase. J. Biol. Chem. 268:14820-14825.
28. Talpaert, M., F. Campagnari, and L. Clerici. 1975. Lipiarmycin: an antibiotic inhibiting nucleic acid polymerases. Biochem. Biophys. Res. Commun. 63:328-334.
29. von Eiff, C., G. Peters, and C. Heilmann. 2002. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect. Dis. 2:677-685.
30. Yang, X., and C. W. Price. 1995. Streptolydigin resistance can be conferred by alterations to either the β or β′ subunits of Bacillus subtilis RNA polymerase. J. Biol. Chem. 270:23930-23933.
31. Zheng, Z., and P. S. Stewart. 2002. Penetration of rifampin through Staphylococcus epidermidis biofilms. Antimicrob. Agents Chemother. 46:900-903.